NCT01721070View on ClinicalTrials.gov

Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Pharmacokinetics
Interventions
DRUG

Sufentanil NanoTab (SUF NT) 15 mcg

Period 1: One dose of SUF NT 15 mcg administered sublingually

DRUG

Ketoconazole 400 mg, sufentanil NanoTab (SUF NT) 15 mcg

Period 2: Ketoconazole 400 mg administered daily for three days, SUF NT 15 mcg co-administered sublingually on the third day

Trial Locations (1)

66219

PRA, Lenexa

All Listed Sponsors
lead

Talphera, Inc

INDUSTRY

NCT01721070 - Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics | Biotech Hunter | Biotech Hunter